
Tuberculosis Is Becoming Harder to Treat: Why Drug Resistance Remains a Challenge Beyond Central Asia
Tuberculosis (TB) remains one of the major threats to public health. It is also a clear example of antimicrobial resistance (AMR): bacteria belonging to the Mycobacterium tuberculosis complex, which cause the disease, can develop resistance to anti-TB medicines. As a result, treatment becomes more complicated. Resistance to rifampicin, one









